Saturday, May 26, 2012

Suven receives ANDA approval for Malathion

Suven has received approval for Malathion in the US. Malathion is an approved prescription drug for the treatment of head lice. The drug is copromoted under the brand name Ovide by Taro and Nextwave.  Mylan is the other generic company to have an approval for generic malathion.
The U.S. Centers for Disease Control and prevention estimates between 6 to 12 million cases of head lice infestations each year

No comments:

Post a Comment